Phreesia, Inc. (PHR)
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
$13.18+7.77%
Close 2026-11-04 · 1-day change
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
QuarterlyIQ Insights · PHR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -15.2% |
| Our one-year growth estimate | diamond | 4.6% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 19.9 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has erratic recent earnings surprises and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 9 industry peers
PHR — earnings miss
Dated 2026-09-02
Results of Operations and Financial Condition On September 2, 2026, Phreesia, Inc. (the “Company”) announced its financial results for the fiscal second quarter ended July 31, 2026 by issuing a stakeholder letter (the "Letter") and a press release. Copies of the press release and the Letter are furnished as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K and are incorporated by reference herein. The information furnished under this
Why it matters: This tests whether lower drug-maker spending stays within the range Phreesia has set. The next report is due December 14, 2026.
Watch forFY2027 revenue guidance stays at $510M–$520M, with network solutions revenue in line with the plan.
Also watch forPhreesia cuts FY2027 revenue guidance below $510M or reports network solutions revenue below its plan.
Why it matters: This tests whether cost cuts and AI savings can support profit growth as revenue growth slows.
Watch forPhreesia keeps FY2027 Adjusted EBITDA guidance at $125M–$135M and reports results within that range.
Also watch forPhreesia cuts its FY2027 Adjusted EBITDA guidance below $125M. Or it reports results below that level.
Why it matters: AccessOne is a key growth effort and is part of the current revenue plan. Its financing depends on access to capital.
Watch forPhreesia reports AccessOne revenue near its $37M FY2027 contribution plan. It expands use of its financing offer.
Also watch forPhreesia lowers its $37M contribution plan. Or it reports limits on offering AccessOne financing to more clients.
Why it matters: More healthcare clients can support growth across Phreesia's products. Recent client growth was 6% year over year.
Watch forThe next report shows AHSC growth in the mid-single digits or higher, near the stated FY2027 outlook.
Also watch forThe next report shows AHSC growth below mid-single digits or a cut to the client growth outlook.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$147 on $10,000 · ±1.5% | How much price usually moves either way. |
| Bad day | $522 loss on $10,000 · 5.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,518 loss on $10,000 · 65.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.